A cancer-associated cysteine-to-phenylalanine point mutation in the zinc finger domain of Mdm2 causes disruption of L11 and L5 binding to Mdm2 [10], and based on this in vitro data, we previously generated a knock-in mouse with the Mdm2 C305F mutation. Here, MDM2 is linked to cancer.